ILC3-myeloid cell crosstalk during homeostatic maintenance of the epithelial barrier and during IBD
A02
Mechanisms linking IFN-mediated cell death with bile acid signaling in small intestinal inflammation
A03
Mucosal immunity as regulator of epithelial cell functions in inflammatory bowel diseases
A05
Oncostatin M as a modulator of pathogenic memory T cells in IBD
A06
Molecular mechanisms and therapeutic implications of vascular permeability defects in inflammatory bowel diseases
A07
The Mevalonate pathway as a checkpoint for regulation of prenylation within intestinal epithelial cells in the context of inflammation
A08
Molecular and functional studies on the crosstalk between induced IEL and IECs in intestinal homeostasis and inflammation
A09
Characterizing the impact of somatic mutations in immune and epithelial cell communication in ulcerative colitis
B01
Mesenteric fat – an immunological barrier in Crohn’s disease?
B02
Signals mediating crosstalk of intestinal epithelial cells with innate lymphoid cells in inflammatory bowel diseases
B03
Dissecting the role of epithelial inflammasome activation in regulating immune responses in colitis
B04
Emergency barriers in Inflammatory Bowel Diseases – Neutrophil-epithelial crosstalk shapes epithelial restitution in the ulcer microenvironment
B05
Impact of epithelial dysfunction on neuroimmune crosstalk in IBD
B06
Interplay of the impaired tight junction and the subjacent immune cells in IBD
B07
Dissecting microbial subcellular structures as targets for specific Treg-based therapies
B08
Direct and indirect crosstalk of epithelial GPR15L with immune cells via the intestinal microbiome in the pathogenesis of IBD
C01
Label-free endoscopic analysis of immune-epithelial communication with advanced optical technologies
C03
Transcranial direct current stimulation for chronic, IBD associated abdominal pain and the relation of pain perception and the intestinal epithelial barrier
C04
A phase II multi-center clinical trial to study the efficacy and in vivo trafficking of autologous adoptively transferred ex vivo expanded regulatory T cells in patients with ulcerative colitis
Z01
Integrated Research Training Group (iRTG)
Z02
Central Administrative Project
Z03
IBDome
Diese Website benutzt Cookies. Wenn Sie die Website weiter nutzen, gehen wir von Ihrem Einverständnis aus.
